跳至主要内容
临床试验/JPRN-C000000323
JPRN-C000000323已完成未知

Prospective Randomized Controlled trial of low dose long term Peg-Interferon alpha-2a treatment after curative ablation for Hepatocellular Carcinoma - Low dose Peg-IFN after Ablation for HCC

Department of Gastroenterology University of Tokyo0 个研究点目标入组 90 人开始时间: 2006年3月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
90

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • Patient with 1.Drug allergy against Interferon. 2.Allergy against biological drugs. 3.Poorly controlled heart disease. 4.Extrahepatic metastasis of HCC 5.Active cancer of other organ. 6.Severe renal dysfunction; BUN>30mg/dL, or Cre>2.0mg/dL 7.on the herb treatment 8.other chronic liver disease like AIH or hepatitisB 9.Depression 10.on other clinical trial 11. any reason which medical doctor regard the patient as unsuitable for this test.

研究者

发起方
Department of Gastroenterology University of Tokyo

相似试验

Prospective Randomized Controlled trial of low dose... | 临床试验